Voriconazole resistance in Aspergillus fumigatus: Should we be concerned?

Clinical Infectious Diseases

Volumn 57, Issue 4, 2013, Pages 521-523

  Denning, David W ^a,b   Bowyer, Paul ^a,b  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Fumigatus; Fungicide; Mycosphaerella; Posaconazole; Triazole

Indexed keywords

AMPHOTERICIN B; BROMUCONAZOLE; ECHINOCANDIN; EPOXICONAZOLE; ITRACONAZOLE; PESTICIDE; POSACONAZOLE; PROPICONAZOLE; TEBUCONAZOLE; UNCLASSIFIED DRUG; VORICONAZOLE;

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ANTIBIOTIC RESISTANCE; ASPERGILLOSIS; ASTHMA; CROP PROTECTION; DEVELOPED COUNTRY; IMMUNOCOMPROMISED PATIENT; INVASIVE ASPERGILLOSIS; LUNG ASPERGILLOSIS; LUNG TUBERCULOSIS; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MUTATION; NOTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SURVIVAL RATE;

FUMIGATUS; FUNGICIDE; MYCOSPHAERELLA; POSACONAZOLE; TRIAZOLE;

AIR MICROBIOLOGY; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; DRUG RESISTANCE, FUNGAL; FEMALE; HUMANS; MALE; MOLECULAR TYPING; PYRIMIDINES; RESIDENCE CHARACTERISTICS; TRIAZOLES;

EID: 84880929672     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit321     Document Type: Note

References (14)

1. Howard SJ, Arendrup MC. Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection. Med Mycol 2011; 49(suppl 1):S90-5.
2. van der Linden JWM, Camps SMT, Kampinga GA, et al. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domestic homes. Clin Infect Dis 2013; 57:513-20.
3. van der Linden JW, Snelders E, Kampinga GA, et al. Clinical implications of azole resistance in Aspergillus fumigatus, the Netherlands, 2007-2009. Emerg Infect Dis 2011; 17:1846-54.
4. Howard SJ, Cesar D, Anderson MJ, et al. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis 2009; 15: 1068-76.
5. Chrdle A, Mustakim S, Bright-Thomas R, Baxter C, Felton T, Denning DW. Aspergillus bronchitis in non-immunocompromised patients: case series, response to treatment and criteria for diagnosis. Ann NY Acad Sci 2012; 1272:73-85.
6. Brown GD, Denning DW, Gow NAR, Levitz S, Netea M, White T. Human fungal infections: the hidden killers. Sci Transl Med 2012; 4:165rv13.
7. Denning DW, Pleuvry A, Cole DC. Global burden of chronic pulmonary aspergillosis as a sequel to tuberculosis. Bull WHO 2011; 89:864-72.
8. Denning DW, Pleuvry A, Cole DC. Global burden of ABPA in adults with asthma and its complication chronic pulmonary aspergillosis. Med Mycol 2013; 51:361-70.
9. Denning DW, Park S, Lass-Florl C, et al. High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis 2011; 52:1123-9.
10. Nivoix Y, Velten M, Letscher-Bru V, et al. Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis 2008; 47:1176-84.
11. European Centre for Disease Prevention and Control. Risk assessment on the impact of environmental usage of triazoles on the development and spread of resistance to medical triazoles in Aspergillus species. Stockholm, Sweden: ECDC, 2013. Available at: http://ecdc.europa.eu/en/publications/techni cal-reports/Pages/index.aspx. Accessed 1 May 2013.
12. Snelders E, Camps SM, Karawajczyk A, et al. Triazole fungicides can induce crossresistance to medical triazoles in Aspergillus fumigatus. PLoS One 2012; 7:e31801.
13. European Crop Protection Association. Assessment of the socio-economic importance of azoles in European agriculture. Available at: www.ecpa.eu/article/ agriculture-today/assess ment-economic-importance-azoles-europeanagriculture- wheat-case-stud.
14. Mullins JG, Parker JE, Cools HJ, et al. Molecular modelling of the emergence of azole resistance in Mycosphaerella graminicola. PLoS One 2011; 6:e20973.